Alliance Pharma plc (LON:APH) Declares Dividend Increase – GBX 1.07 Per Share

Alliance Pharma plc (LON:APH) announced a dividend on Tuesday, March 23rd, Upcoming.Co.Uk reports. Stockholders of record on Thursday, June 10th will be paid a dividend of GBX 1.07 ($0.01) per share on Thursday, July 8th. This represents a dividend yield of 1.23%. The ex-dividend date is Thursday, June 10th. This is an increase from Alliance Pharma’s previous dividend of $0.54. The official announcement can be viewed at this link.

Shares of Alliance Pharma stock opened at GBX 100.20 ($1.31) on Wednesday. The business has a fifty day moving average of GBX 95.94. The firm has a market capitalization of £535.90 million and a P/E ratio of 66.40. The company has a debt-to-equity ratio of 50.56, a quick ratio of 1.76 and a current ratio of 2.56. Alliance Pharma has a 1 year low of GBX 68.08 ($0.89) and a 1 year high of GBX 105 ($1.37).

In other news, insider Peter Butterfield sold 93,000 shares of the firm’s stock in a transaction on Wednesday, April 21st. The shares were sold at an average price of GBX 95 ($1.24), for a total value of £88,350 ($115,429.84).

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in the United Kingdom, Republic of Ireland, Mainland Europe, the United States, and internationally. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It owns or licenses the rights to approximately 80 pharmaceutical and consumer healthcare products.

Recommended Story: Return on Equity (ROE)

Dividend History for Alliance Pharma (LON:APH)

Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.